Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rohan Dhamsania"'
Autor:
Sruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, Shuhua Wang, Rohan Dhamsania, Michael Brandon Ware, Mohammad Y. Zaidi, Jingru Zhu, Maria Cardenas, Yuan Liu, Sanjeev Gumber, Brian Robinson, Anish Sen-Majumdar, Hanwen Zhang, Shanmuganathan Chandrakasan, Haydn Kissick, Alan B. Frey, Susan N. Thomas, Bassel F. El-Rayes, Gregory B. Lesinski, Edmund K. Waller
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Poor antitumor response of pancreatic cancer to immunotherapies is a major barrier to effective disease management. Herein we show that pancreatic cancers overexpress vasoactive intestinal peptide, and pharmacological inhibition of its signaling sign
Externí odkaz:
https://doaj.org/article/954e43b7b1f84c9eb8712e29586d1565
Autor:
Yuan Liu, Susan Thomas, Mohammad Zaidi, Shuhua Wang, Haydn Kissick, Gregory Lesinski, Alan Frey, Sruthi Ravindranathan, Edmund Waller, Michael Ware, Bassel El-rayes, Rohan Dhamsania, Jingru Zhu, Anish Majumdar, Brian Robinson, Maria Cardenas, Tenzin Passang Fnu, Jian Ming Li, Sanjeev Gumber, Shanmuganathan Chandrakasan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ef457d1db40045839ffa75158ef24e6a
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/1f4037cf49074d6d92319e9d45a09283
Autor:
Sruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, Shuhua Wang, Rohan Dhamsania, Michael Brandon Ware, Mohammad Y. Zaidi, Jingru Zhu, Maria Cardenas, Yuan Liu, Sanjeev Gumber, Brian Robinson, Anish Sen-Majumdar, Hanwen Zhang, Shanmuganathan Chandrakasan, Haydn Kissick, Alan B. Frey, Susan N. Thomas, Bassel F. El-Rayes, Gregory B. Lesinski, Edmund K. Waller
Publikováno v:
Nature communications. 13(1)
A paucity of effector T cells within tumors renders pancreatic ductal adenocarcinoma (PDAC) resistant to immune checkpoint therapies. While several under-development approaches target immune-suppressive cells in the tumor microenvironment, there is l
Publikováno v:
Cancer Research. 82:2634-2634
Background: In cancer immunology, VIP is a neuropeptide with pleiotropic effects that include inhibiting T cell activation, increasing Treg frequency, and augmenting the myeloid-derived suppressor cells function. VIP expression by cancer may represen